The Swedish startup CELLINK, that has launched their universal bioink kits for 3D printing earlier this year, is now partnering with RoosterBio, a company producing stem cells.
This collaboration will enable the two companies to launch the first commercial inks for 3D bioprinting containing living cells.
RoosterBio’s products are human bone marrow- and adipose-derived mesenchymal stem cells (hMSC). Combined with CELLINK’s hydrogel bioink, a printable mixture is created, which can be used for 3D bioprinting of functional living human tissues for research and drug testing. Ultimately, it could be used to 3D print human organs and tissues for patients in need of transplants.
Instead of having to mix CELLINK with their own living cells, researchers and other customers will be able to buy ready-to-use kits containing 3D printable hydrogel and stem cells, reducing time consuming preparation time.
The new kits were first presented at the 2015 TERMIS World Congress in Boston taking place earlier this month.